|COVID-19 pandemic in Saint Helena, Ascension and Tristan da Cunha|
|Location||Saint Helena, Ascension and Tristan da Cunha|
|Arrival date||24 December 2020|
(6 months and 6 days)
|https://www.ascension.gov.ac/government/news https://www.sainthelena.gov.sh/coronavirus-covid-19/communications/ https://www.tristandc.com/government.php|
|‡Suspected cases have not been confirmed by laboratory tests as being due to this strain, although some other strains may have been ruled out.|
This article lists links to articles relating to the ongoing COVID-19 pandemic within Saint Helena, Ascension and Tristan da Cunha.
On 27 March 2020 the Saint Helena government announced a suspected case of COVID-19 in an individual that had been self-isolating since 21 March.Owing to Saint Helena's remote location, no testing facilities were readily available at that time. The case later tested negative.
On 5 January 2021, the first doses of the Oxford–AstraZeneca COVID-19 vaccine were delivered to Saint Helena and began to be administered.
On 26 March 2021, Health Directorate of Saint Helena reported a low positive case, a passenger arrived by flight on 24 March.The passenger was tested negative on 29 March 2021.
On 27 March 2021, Saint Helena government announced an unspecified number of positive cases on a fishing vessel.
On 5 May 2021, the Government of Saint Helena announced that 3,528 residents had received both doses of the vaccine; this represents 95.1% of Saint Helena's adult population and 77.8% of its total population.
On 16 March 2020, three people who arrived by air to Ascension Island showed symptoms of COVID-19.However, on 23 March it was announced that they had tested negative on 22 March.
On 7 September 2020, the Ascension Island Government announced two weak positives cases on two peoples arrived on 4 September with a negative test result.The two cases were tested negatives and confirmed as historical infection on 9 September.
On 16 November 2020, the Ascension Island Government reported one other weak positive case,subsequently tested negative on 18 November.
On 24 December 2020, the Ascension Island Government announced a positive case in isolation.The case was tested negative on 6 January 2021.
On 16 February 2021, 1950 doses of the Oxford-AstraZeneca vaccine were delivered by the Royal Air Force; vaccinations began the next day.By March 25, 798 of Ascension's 806 people (99%) had received at least one dose of the vaccine.
On 16 April 2021, a new positive case is reported on an individual arrived on 14 April and mildly symptomatic.On 26 April, the case is confirmed to be negative.
On 16 March 2020, the Tristan da Cunha Island Council on Tristan da Cunha made the decision, as a precaution, to ban visitors to the island to prevent the potential transmission of the disease to islanders.
On 21 April 2021, HMS Forth delivered enough Oxford-AstraZeneca vaccine for the whole island to be completely vaccinated.Vaccinations began on April 28 though data has not yet been released on the percentage of people that have received them.
As of 27 April 2021, there have been no reported cases of the coronavirus.
The Therapeutic Goods Administration (TGA) is the medicine and therapeutic regulatory agency of the Australian Government. As part of the Department of Health, the TGA regulates the quality, supply and advertising of medicines, pathology devices, medical devices, blood products and most other therapeutics. Any items that claim to have a therapeutic effect, are involved in the administration of medication, or are otherwise covered by the Therapeutic Goods Act 1989, the Therapeutic Goods Regulations 1990, or a ministerial order, must be approved by the TGA and registered in the Australian Register of Therapeutic Goods.
The COVID-19 pandemic was confirmed to have spread to Africa on 14 February 2020, with the first confirmed case announced in Egypt. The first confirmed case in sub-Saharan Africa was announced in Nigeria at the end of February 2020. Within three months, the virus had spread throughout the continent, as Lesotho, the last African sovereign state to have remained free of the virus, reported a case on 13 May 2020. By 26 May, it appeared that most African countries were experiencing community transmission, although testing capacity was limited. Most of the identified imported cases arrived from Europe and the United States rather than from China where the virus originated.
The COVID-19 pandemic in the Isle of Man is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have reached the British crown dependency of the Isle of Man on 19 March 2020, when a man returning from Spain via Liverpool tested positive. Community transmission was first confirmed on 22 March on the island. By June 2021, there had been 1,611 confirmed cases of COVID-19, of which 1,569 have presumably recovered and 29 have died.
Operation Broadshare is the code name for the British military operation to address the COVID-19 pandemic overseas, primarily in the British Overseas Territories (BOTs) and British overseas military bases. The operation runs in parallel to a similar military operation in the United Kingdom, named Operation Rescript.
The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed by Oxford University and AstraZeneca, it is given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. Another analysis showed that, for symptomatic COVID-19 infection after the second dose, the vaccine is 66% effective against the Alpha variant, and 60% against the Delta variant.
The following is a timeline of the COVID-19 pandemic in the United Kingdom during 2021. There are significant differences in the legislation and the reporting between the countries of the UK: England, Scotland, Northern Ireland, and Wales. The numbers of cases and deaths are reported on a government Web site updated daily during the pandemic. The UK-wide COVID Symptom Study based on surveys of four million participants, endorsed by authorities in Scotland and Wales, run by health science company ZOE, and analysed by King's College London researchers, publishes daily estimates of the number of new and total current COVID-19 infections in UK regions, without restriction to only laboratory-confirmed cases.
The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.
The general COVID-19 vaccination in Australia programme began on 22 February 2021, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) has approved two vaccines in Australia: the Pfizer–BioNTech vaccine on 25 January, and the Oxford–AstraZeneca vaccine on 16 February. After the AstraZeneca vaccine was found to cause rare blood clotting complications in some people, its use was only recommended for those 50 years and older, which after 2 deaths in Australia was raised to those 60 years and over. In June 2021, the Federal government projected that the Oxford-AstraZeneca vaccine would see "little need" after October 2021 when all over 60 year-old Australians were expected to be immunised.
As of 30 June 2021, Australia has administered 7,645,585 vaccine doses across the country.
A dispute broke out in January 2021 between the European Commission and the pharmaceutical company AstraZeneca AB about the provision of COVID-19 vaccines during the COVID-19 pandemic, and, in February, spilled out into a dispute over Article 16 of the Northern Ireland Protocol. Vaccination proceeded apace in the UK but more slowly in the EU, and by the end of March 2021, over 30% of the UK population had received at least one dose of vaccine compared to about 8% of the EU population. This was partly due to limited availability of the AstraZeneca vaccine in the EU. The World Health Organization and the European Medicines Agency continued to state that the vaccine was safe and effective. However, a representative of the European Medicines Agency said in June that vaccines based on the mRNA technology should be preferred if available for all age groups, including for the over 60s.
The COVID-19 vaccination programme in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer approved COVID-19 vaccines during the COVID-19 pandemic in Canada. Some provinces have asked local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history; it started in mid-December and is currently ongoing.
COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021. As of 29 June 2021, 17,941,952 vaccine doses have been administered across the country, 6,566,762 people have received two doses and 87,968 people have been vaccinated with single-dose vaccines.
COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 6 April 2021, vaccination campaigns had started in 33 African countries and 8.7 million persons had received at least one dose. Four weeks later, the number of countries where vaccination campaigns had started was 47 and 14.7 million persons had received at least one dose.
Post-vaccination embolic and thrombotic events, also termed vaccine-induced prothrombotic immune thrombocytopenia (VIPIT), vaccine-induced immune thrombotic thrombocytopenia (VITT), or thrombosis with thrombocytopenia syndrome (TTS) are rare types of blood clotting events that were initially observed in a very small number of people who had previously received the Oxford–AstraZeneca COVID-19 vaccine (AZD1222) during the COVID-19 pandemic. It was subsequently also described in the Johnson & Johnson COVID-19 vaccine leading to suspension of its use until its safety had been reassessed.
The COVID-19 vaccination in Vietnam is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 30 January 2021, vaccinations commenced on 8 March 2021, and will continue throughout the year with the goal of vaccinating 80% of the population by June 2022. The Sputnik V was later approved for use on 23 March 2021. Sinopharm COVID-19 vaccine was approved for emergency use on 4 June 2021, while Pfizer–BioNTech COVID-19 vaccine and Moderna COVID-19 vaccine was approved on 12 June 2021 and 29 June 2021, respectively.
The COVID-19 pandemic was confirmed to have spread to Africa on 14 February 2020, with the first confirmed case announced in Egypt. The first confirmed case in sub-Saharan Africa was announced in Nigeria at the end of February. Within three months, the virus had spread throughout the continent, as Lesotho, the last African sovereign state to have remained free of the virus, reported a case on 13 May. By 26 May, it appeared that most African countries were experiencing community transmission, although testing capacity was limited. Most of the identified imported cases arrived from Europe and the United States rather than from China where the virus originated. It is believed that there is widespread under-reporting in many African countries with less developed healthcare systems.
COVID-19 vaccination in South Korea is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. By June, Indonesia has secured at least 118.7 million doses of COVID-19 vaccines: 108.5 million from Sinovac, 8.2 million from AstraZeneca, and two million from Sinopharm.
COVID-19 vaccination in Sri Lanka is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.
COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country. Following the approval of the Oxford–AstraZeneca COVID-19 vaccine on 18 March 2021, vaccinations commenced on 22 March 2021, and will continue throughout the year with the goal of vaccinating 60% of the population by October 2021.